The Effect of Diffuse Pulmonary Fibrosis on the Reliability of CT Signs of Pulmonary Hypertension

Purpose: To determine whether pulmonary artery (PA) dilatation is a reliable indicator of pulmonary hypertension (PH) in patients with pulmonary fibrosis.

Materials and Methods: This study had institutional review board approval. Patient consent was not required. Seventy-seven patients (39 men, 38 women) who underwent right heart catheterization were studied. The study population was divided into 30 patients with pulmonary fibrosis (group A), and 47 without (group B). The main PA diameter (dPA) and ascending aorta diameter (dAA) were measured by using computed tomography (CT), and the extent of fibrosis was recorded in group A. The dPA and the dPA/dAA ratio were correlated (Spearman rank) with mean PA pressure (mPAP) and pulmonary vascular resistance index (PVRi). The relationship between dPA and pulmonary fibrosis extent and total lung capacity (TLC) was examined by using multivariate linear regression.

Results: There were strong correlations between dPA and both mPAP (r = 0.67, P < .0001) and PVRi (r = 0.78, P < .0001) in group B. In contrast, there were no significant correlations in group A (r = 0.23, P = .22 for mPAP and r = 0.23, P = .28 for PVRi). The dPA/dAA ratio had similar relationships to dPA alone in group B (r = 0.72, P < .0001 for mPAP and r = 0.71, P < .0001 for PVRi), but significantly strengthened the correlations in group A (r = 0.54, P < .005 for mPAP and r = 0.48, P = .04 for PVRi). PA dilatation occurred in group A in the absence of significant PH, and was unrelated to CT fibrosis score or TLC.

Conclusion: PA dilatation occurs in the absence of PH in patients with pulmonary fibrosis and is therefore an unreliable sign of PH in these patients.

© RSNA, 2008

References

  • 1 King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171–1181. Crossref, MedlineGoogle Scholar
  • 2 Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746–752. Crossref, MedlineGoogle Scholar
  • 3 Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128: 2393–2399. Crossref, MedlineGoogle Scholar
  • 4 Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007; 30: 715–721. Crossref, MedlineGoogle Scholar
  • 5 Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650–656. Crossref, MedlineGoogle Scholar
  • 6 Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167: 735–740. Crossref, MedlineGoogle Scholar
  • 7 Haimovici JB, Trotman-Dickenson B, Halpern EF, et al. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization: Massachusetts General Hospital Lung Transplantation Program. Acad Radiol 1997; 4: 327–334. Crossref, MedlineGoogle Scholar
  • 8 Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 1984; 19: 16–22. Crossref, MedlineGoogle Scholar
  • 9 Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999; 14: 270–278. Crossref, MedlineGoogle Scholar
  • 10 Zisman DA, Karlamangla AS, Ross DJ, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007; 132: 773–779. Crossref, MedlineGoogle Scholar
  • 11 American Thoracic Society (ATS), European Respiratory Society (ERS). ATS/ERS International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias: this joint statement of the ATS, and the ERS was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277–304. [Published correction appears in Am J Respir Crit Care Med 2002;166:426.] Crossref, MedlineGoogle Scholar
  • 12 Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003; 168: 952–958. Crossref, MedlineGoogle Scholar
  • 13 Cook LB, Morgan M. Pulmonary artery catheterisation. Ann Acad Med Singapore 1994; 23: 519–530. MedlineGoogle Scholar
  • 14 Cholley BP, Payen D. Noninvasive techniques for measurements of cardiac output. Curr Opin Crit Care 2005; 11: 424–429. Crossref, MedlineGoogle Scholar
  • 15 Mazza E, Taichman DB. Functions and control of the pulmonary circulation. In: Mandel J, Taichman D, eds. Pulmonary vascular disease. Philadelphia, Pa: Saunders Elsevier, 2006; 1–19. Google Scholar
  • 16 Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known: 1916. Nutrition 1989; 5: 303–311. MedlineGoogle Scholar
  • 17 Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol 1998; 71: 1018–1020. Crossref, MedlineGoogle Scholar
  • 18 Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: 1063–1072. Crossref, MedlineGoogle Scholar
  • 19 Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232: 560–567. LinkGoogle Scholar
  • 20 Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston, Mass: PWS-Kent, 1988. Google Scholar
  • 21 Dupuis J, Hoeper MM. Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008; 31: 407–415. Crossref, MedlineGoogle Scholar
  • 22 McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126(suppl 1): S14–S34. Crossref, MedlineGoogle Scholar
  • 23 Perez-Enguix D, Morales P, Tomas JM, Vera F, Lloret RM. Computed tomographic screening of pulmonary arterial hypertension in candidates for lung transplantation. Transplant Proc 2007; 39: 2405–2408. Crossref, MedlineGoogle Scholar
  • 24 Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease: Medical College of Wisconsin Lung Transplant Group. Chest 1998; 113: 1250–1256. Crossref, MedlineGoogle Scholar
  • 25 Nava S, Rubini F. Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis. Thorax 1999; 54: 390–395. Crossref, MedlineGoogle Scholar
  • 26 Chang SM, Lin CC, Hsiao SH, et al. Pulmonary hypertension and left heart function: insights from tissue Doppler imaging and myocardial performance index. Echocardiography 2007; 24: 366–373. Crossref, MedlineGoogle Scholar
  • 27 Turner-Warwick M. Precapillary systemic-pulmonary anastomoses. Thorax 1963; 18: 225–237. Crossref, MedlineGoogle Scholar
  • 28 Wells AU, Hansell DM, Rubens MB, Cailes JB, Black CM, du Bois RM. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am J Respir Crit Care Med 1997; 155: 1657–1664. Crossref, MedlineGoogle Scholar
  • 29 Cudkowicz L, Calabresi M, Nims RG, Gray FD Jr. The simultaneous estimation of right and left ventricular outputs applied to a study of the bronchial circulation in patients with chronic lung disease. Am Heart J 1959; 58: 743–749. Crossref, MedlineGoogle Scholar
  • 30 Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 2007; 175: 875–880. Crossref, MedlineGoogle Scholar
  • 31 Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007; 132: 998–1006. Crossref, MedlineGoogle Scholar
  • 32 Rubin LJ. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126(suppl 1): S7–S10. Crossref, MedlineGoogle Scholar
  • 33 Shigemitsu H, Nagai S, Sharma OP. Pulmonary hypertension and granulomatous vasculitis in sarcoidosis. Curr Opin Pulm Med 2007; 13: 434–438. Crossref, MedlineGoogle Scholar

Article History

Published in print: 2008